Renaissance Technologies (RenTech)'s SGMT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 346,927 shares of Sagimet Biosciences Inc. (SGMT) worth $2.68 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SGMT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 396,400 shares. Largest reduction occurred in Q2 2026, reducing 278,542 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Sagimet Biosciences (SGMT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sagimet Biosciences (SGMT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -278,542 | Reduce 44.53% | 346,927 | $7.73 |
| Q1 2026 | +282,969 | Add 82.62% | 625,469 | $5.23 |
| Q4 2025 | +181,100 | Add 112.21% | 342,500 | $5.92 |
| Q3 2025 | +130,500 | Add 422.33% | 161,400 | $6.86 |
| Q2 2025 | +30,900 | New Buy | 30,900 | $7.62 |
| Q1 2025 | -10,800 | Sold Out | 0 | $0.00 |
| Q4 2024 | -220,300 | Reduce 95.33% | 10,800 | $4.50 |
| Q3 2024 | -11,300 | Reduce 4.66% | 231,100 | $2.77 |
| Q2 2024 | -177,000 | Reduce 42.20% | 242,400 | $3.42 |
| Q1 2024 | +396,400 | Add 1723.48% | 419,400 | $5.42 |
| Q4 2023 | +23,000 | New Buy | 23,000 | $5.43 |
Renaissance Technologies (RenTech)'s Sagimet Biosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Sagimet Biosciences Inc. (SGMT) in Q4 2023, acquiring 23,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Sagimet Biosciences Inc. (SGMT) for 11 quarters since Q4 2023.
Renaissance Technologies (RenTech)'s largest addition to Sagimet Biosciences Inc. (SGMT) was in Q1 2024, adding 419,400 shares worth $2.27 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 346,927 shares of Sagimet Biosciences Inc. (SGMT), valued at approximately $2.68 M.
As of the Q2 2026 filing, Sagimet Biosciences Inc. (SGMT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Sagimet Biosciences Inc. (SGMT) was 625,469 shares, as reported at the end of Q1 2026.